Clinical Characteristics and Prognosis of Aortic Dissection in China (CLASSIC)

Sponsor
First Affiliated Hospital Xi'an Jiaotong University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05999188
Collaborator
521 Hospital of NORINCO Group (Other), Shaanxi Provincial People's Hospital (Other), Xiangyang Central Hospital (Other), Henan Provincial People's Hospital (Other)
100
1
85.4
1.2

Study Details

Study Description

Brief Summary

This study will construct a retrospective-prospective long-term follow-up cohort and management system for aortic dissection through a multicentre collaborative network. This study aims to investigate the disease characteristics, progression patterns, clinical features, natural course and factors affecting the disease course and prognosis of patients with aortic dissection by retrospectively collecting data and prospectively enrolling patients.

Condition or Disease Intervention/Treatment Phase
  • Other: Observational

Detailed Description

This study aims to construct a retrospective-prospective long-term follow-up cohort and management system for aortic dissection through a multicentre collaborative network. The duration of the study will be divided into retrospective and prospective components. The retrospective study will collect cases of aortic dissection of different aetiologies from 2003-2022; the prospective study is expected to collect cases of aortic dissection from 2022-2030. The study is expected to assess the disease characteristics, progression patterns, clinical features, natural course and long-term prognosis of aortic coarctation.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
Clinical Characteristics and Prognosis of Aortic Dissection in China (CLASSIC): a National, Multicenter, Retrospective-prospective, Cohort Study
Anticipated Study Start Date :
Oct 30, 2023
Anticipated Primary Completion Date :
Oct 12, 2030
Anticipated Study Completion Date :
Dec 12, 2030

Arms and Interventions

Arm Intervention/Treatment
Aortic dissection group

Patients diagnosed with aortic dissection at any of the centres and regularly consulted and followed up.

Other: Observational
No interventions will be given to patients.

Outcome Measures

Primary Outcome Measures

  1. Change of post-operative survival rate [3, 6, 9 month and 1, 2, 3, 4, 5 year after the surgery.]

    Post-operative survival rate of patients after aortic dissection surgery in 3, 6, 9 month and 1, 2, 3, 4, 5 year. The survival situation will be assessed by telephone follow-up.

Secondary Outcome Measures

  1. Change of the incidence of MACCE [3, 6, 9 month and 1, 2, 3, 4, 5 year after the surgery.]

    Major adverse cardio-cerebrovascular events included myocardial infarction, stroke, revascularization and all-cause death. The occurrence of MACCE will be assessed by telephone follow-up and medical records.

  2. Incidence of any complications [5 years after the surgery.]

    Any complications diagnosed by doctors. The occurrence of complications will be decided by medical records.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18-80 years;

  • Meet diagnostic criteria for aortic dissection.

Exclusion Criteria:
  • Age <18 years or >80 years;

  • Women who are pregnant and breastfeeding;

  • Patients and their families refuse or are unable to sign the informed consent form.

Contacts and Locations

Locations

Site City State Country Postal Code
1 First Affiliated Hospital of Xian Jiantong University Xi'an Shaanxi China 710061

Sponsors and Collaborators

  • First Affiliated Hospital Xi'an Jiaotong University
  • 521 Hospital of NORINCO Group
  • Shaanxi Provincial People's Hospital
  • Xiangyang Central Hospital
  • Henan Provincial People's Hospital

Investigators

  • Principal Investigator: Guoliang Li, First Affiliated Hospital Xi'an Jiaotong University
  • Principal Investigator: Yang Yan, First Affiliated Hospital Xi'an Jiaotong University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
First Affiliated Hospital Xi'an Jiaotong University
ClinicalTrials.gov Identifier:
NCT05999188
Other Study ID Numbers:
  • XJTU1AF2023LSK-313
First Posted:
Aug 21, 2023
Last Update Posted:
Aug 21, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by First Affiliated Hospital Xi'an Jiaotong University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 21, 2023